Status:
UNKNOWN
D2 Dopamine Receptor on Human Aldosterone-Producing Adenoma and Its Role in Aldosterone Secretion and Cell Proliferation
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hypertension
Adrenal Aldosterone-Producing Adenoma
Eligibility:
All Genders
Brief Summary
Dopamine (DA) is one of the main catecholamines in mammals. Its major role as a brain neurotransmitter is well known as well as its contribution to the development of pathologies, mainly arterial hype...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adrenal aldosterone-producing adenoma
Exclusion
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00173446
Start Date
January 1 2002
Last Update
June 8 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100